https://commons.ufh.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 Short term stability testing of efavirenz-loaded solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) dispersions https://commons.ufh.ac.za/vital/access/manager/Repository/vital:44000 90%. The optimized nanocarriers exhibited biphasic in vitro release patterns with an initial burst release during the initial 0–3 h followed by sustained release over a 24 h period The colloidal systems showed excellent stability in terms of Zeta potential, particle size, polydispersity index and encapsulation efficiency when stored for 8 weeks at 25 °C/60% RH in comparison to when stored at 40 °C/75% RH. The formulations manufactured using the optimized conditions and composition proved to be physically stable as aqueous dispersions.]]> Tue 14 May 2024 11:14:37 SAST ]]> Preformulation studies of efavirenz with lipid excipients using thermal and spectroscopic techniques https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43934 Tue 14 May 2024 11:13:58 SAST ]]> Nano-biomimetic drug delivery vehicles: Potential approaches for COVID-19 treatment https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43991 Tue 14 May 2024 11:13:22 SAST ]]> Biocompatibility of biomaterials for nanoencapsulation: Current approaches https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43939 Tue 14 May 2024 11:12:53 SAST ]]> Enhancement of Biological and Pharmacological Properties of an Encapsulated Polyphenol: Curcumin https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43917 Tue 14 May 2024 11:12:23 SAST ]]> The use of experimental design for the development and validation of an HPLC-ECD method for the quantitation of efavirenz https://commons.ufh.ac.za/vital/access/manager/Repository/vital:44006 Tue 14 May 2024 10:59:25 SAST ]]> Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: Method scaling versus re-validation. https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43984 Tue 14 May 2024 10:58:54 SAST ]]> The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43981 Tue 14 May 2024 10:57:46 SAST ]]> Muco-adhesive clarithromycin-loaded nanostructured lipid carriers for ocular delivery: Formulation, characterization, cytotoxicity and stability https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43916 Tue 14 May 2024 10:54:28 SAST ]]>